In this report we elucidated the impact of IUGR on NOSTRIN and its downstream effector gene expression in the utero-placental compartments. We showed here that induction of IUGR by maternal dexamethasone administration in rats led to up-regulation of NOSTRIN transcript and protein in the mesometrial triangle of the uterus (MG) and not in other utero-placental compartments as compared to control. This was associated with down-regulation of twelve genes and four cytokines that were known to be regulated by NOSTRIN and also required for maintenance of pregnancy. Interestingly, there was remarkable decrease in phosphorylation of RelA transcription factor in the MG during IUGR in line with the fact that the down regulated genes harbour RelA transcription activation domain in their promoters. Furthermore, HIF-1α level was reciprocal to NOSTRIN expression pattern in the mesometrial compartment during IUGR and also in CoCl 2 treated endothelial cells. Over-expression of HIF-1α led to a decrease in NOSTRIN levels suggesting inhibition of Nostrin transcription by HIF-1α. Our findings highlight the importance of NOSTRIN in uterine pathophysiology during IUGR.
Results
Induction of IUGR by maternal dexamethasone administration leads to up regulation of NOSTRIN in the mesometrial triangle of the uterus. Dexamethasone administration during last third of gestation led to induction of IUGR, evident from an overall reduction in fetal ( Fig. 1A ) and placental size (Fig. 1B) accompanied by a 41% decrease in fetal weight (Fig. 1C ) and 37% reduction in placental weight (Fig. 1D ). There was significant (p < 0.01) reduction in fetal and placental weight on administration of dexamethasone acetate in Scientific REPORTS | (2018) 8:8342 | DOI:10.1038/s41598-018-26590-3 5 different biological replicates. However, dexamethasone treatment did not affect fetal viability or number of fetuses. Haematoxylin and eosin staining of placental section from control and IUGR-induced placenta (Fig. 1E ) showed that there was no morphological abnormality of the placenta upon dexamethasone administration. This data is in agreement with previously published reports of maternal dexamethasone administration.
Recent reports from our laboratory established the eNOS-independent function of NOSTRIN in vitro. We therefore, sought to analyze NOSTRIN expression in the context of utero-placental development in this rat model of IUGR. To analyze placental response to maternal dexamethasone treatment, Nostrin mRNA expression was assessed in various utero-placental compartments on gestation day 20.5 by quantitative real time PCR. Interestingly, there was no significant change in Nostrin mRNA levels in the junctional and labyrinth zones of the placenta. In contrast, there was remarkable (p < 0.01) up-regulation of NOSTRIN transcripts in the mesometrial compartment of the uterus, i.e., metrial gland ( Fig. 2A ). NOSTRIN protein levels were then monitored by immunoblot assay (Fig. 2B ). Concordant to mRNA levels, expression of NOSTRIN was not substantially altered in the junctional and labyrinth zone of the placenta with respect to the control groups. However, there was a significant (p < 0.005) up-regulation in NOSTRIN protein levels in the metrial gland. Protein levels were also quantified after normalisation with rpL7 as shown in Fig. 2C .
NOSTRIN levels are not altered by Dexamethasone treatment in vitro.
Although our data clearly demonstrated that NOSTRIN levels increased during IUGR, it still remained elusive whether this up-regulation was an influence of dexamethasone treatment or a consequence of IUGR. To address this question, we analysed whether dexamethasone treatment in endothelial cells affects NOSTRIN expression. MS1 endothelial cells were treated with increasing concentrations of dexamethasone. There was no significant change in Nostrin mRNA levels (Fig. 3A ) determined by real time PCR or NOSTRIN protein levels ( Fig. 3B ) assessed by western blotting upon dexamethasone treatment even at highest concentrations of dexamethasone used. NOSTRIN protein levels were quantified and normalised to rpL7 levels (Fig. 3C ). This data indicates that elevated level of NOSTRIN in the mesometrial triangle of the uterus is a consequence of IUGR induction.
IUGR impairs uterine expression of NOSTRIN-regulated genes.
Recent report from our laboratory showed that NOSTRIN negatively regulates several genesin endothelial cells 23 . Since NOSTRIN was significantly (p < 0.005) up-regulated in the metrial gland, we analyzed the expression of these NOSTRIN-regulated genes by real time PCR. Interestingly, these genes were found to be significantly (p < 0.05 or p < 0.01 or p < 0.005 as denoted in figure) affected during IUGR. These included the receptor tyrosine kinases, such as, Flt-1, Kdr, Tek and a pro-angiogenic ligand of Flt-1, i.e., Pgf (Fig. 4A ); adhesion molecules, such as, Itgα5, Itgβ3, Fn1 and Col18a1 (Fig. 4B ); and proteases, such as Mmp2, Adam17 and Plau (Fig. 4C ). Furthermore, NOSTRIN elevation was also associated with down regulation of several cytokines, such as, IL6, Ccl2, Cxcl1 and Cxcl2 (Fig. 4D ) in the metrial gland.
IUGR negatively impacts downstream effector proteins of NOSTRIN.
To correlate the mRNA levels of affected genes with protein levels, either immunoblot assay or ELISA in case of cytokines was performed. All the genes that were down-regulated during IUGR reflected similar pattern of expression at protein levels also. Protein levels of receptor tyrosine kinases (FLT1, KDR, and TEK), pro-angiogenic ligand (PGF), adhesion promoting factors (Itgα5, Itgβ3, FN1 and COL18A1) along with proteases (MMP2, ADAM17 and PLAU) were assessed by immunoblot assay (Fig. 5A ). Protein levels were quantified and normalised to rpL7 ( Fig. 5B ). All the aforesaid molecules were significantly (p < 0.05 or p < 0.01 as denoted in Fig. 5B ) down-regulated by induction of IUGR in the mesometrial triangle of the uterus. There was also a significant decrease (p < 0.05 or p < 0.01 as denoted in Fig. 5C ) in expression of secreted cytokines (IL6, CCL2, CXCL1 and CXCL2) as demonstrated by ELISA ( Fig. 5C ). These results highlight the importance of NOSTRIN and its associated proteins in the mesometrial uterus during IUGR.
RelA phosphorylation is suppressed in the mesometrial uterus upon IUGR induction. Recent
data from our lab showed that NOSTRIN over-expression results in inhibition of NFκB signaling pathway 23 . Besides, promoter analysis and literature survey of the 11 genes along with the 4 cytokines that were affected during IUGR revealed that 9 out of 11 of the genes had NFκB response element. Cytokines IL6, CCL2, CXCL1 and CXCL2 have previously been demonstrated as direct targets of Rel transcription factors by chromatin immunoprecipitation assays. We, therefore, sought to investigate the phosphorylation status of RelAin the mesometrial uterus of IUGR rats. Nuclear factor κB (NF-κB)/Rel (p65) transcription factor having trans-activation domains are present in the cytosol in an inactive state, complexed with the inhibitory proteins. Phosphorylation of p65/ RelA enhances its transcriptional activity. By immunoblot assay, we compared the protein levels of the p65/RelA and phosphorylated p65/RelA in uterine mesometrial triangle of control and IUGR rats. Interestingly, we found a significant (p < 0.005) decrease in the phosphorylation of p65 subunit in IUGR, whereas the total p65 levels remained unaltered as expected ( Fig. 6A,B ). Furthermore, we analyzed the levels of phosphorylated p65 in endothelial cells treated with dexamethasone by immunoblot assay (Fig. 6C ) since corticosteroids are known to inhibit transcriptional activation of NFκB by various mechanisms 24, 25 . There was no significant change in basal expression of p65 or activation of p65 by phosphorylation. Protein levels of pp65 were quantified and normalised to rpL7 levels ( Fig. 6D ). This data indicates that suppression of RelA phosphorylation in the uterine mesometrial triangle is not a consequence of dexamethasone treatment.
NOSTRIN is negatively regulated by HIF1α in IUGR-induced mesometrial uterus. Maternal
hypoxia is known to be associated with development of IUGR 26 . Hypoxia inducible factor-1α (HIF-1α) is a master transcriptional regulator that is up-regulated under hypoxic conditions. Bioinformatic analysis showing the presence of hypoxia response element in NOSTRIN promoter indicates that HIF-1α may be a regulator of NOSTRIN transcription. We, therefore, analysed the protein levels of HIF-1α in the mesometrial compartment of dexamethasone induced IUGR by immunoblot assay and found a significant (p < 0.005) decline in HIF-1α levels by 70% ( Fig. 7A) where NOSTRIN was up-regulated (See Fig. 2B ). HIF-1α protein levels were also quantified and normalised to rpL7 (Fig. 7B ). This reciprocal expression pattern of HIF-1α and NOSTRIN in vivo prompted us to induce and mimic hypoxia by CoCl 2 treatment in endothelial cells. Interestingly, there was a dose dependant decrease in NOSTRIN levels on gradual induction of HIF-1α ( Fig. 7C ). Both HIF-1α and NOSTRIN protein Nostrin mRNA levels ( Fig. 7E ). Concordant to mRNA levels there was significant decline (p < 0.05) in NOSTRIN protein levels by over-expression of HIF-1α ( Fig. 7F ). Protein levels were quantified and normalised to rpL7 (Fig. 7G ). Taken together, these data indicate that HIF-1α negatively regulate Nostrin transcription. 
Discussion
Several genes known to be regulator of angiogenesis have been implicated in IUGR as compromised development of the utero-placental vascular network leads to placental insufficiency [27] [28] [29] [30] . Our data, for the first time, show that gene network in the uterus located at the vicinity of the developing placenta also is affected by IUGR. Gene ontology analysis of transcripts in the mesometrial compartment of the utero-placental section shows enrichment of genes required for vasculature development highlighting the importance of the metrial gland in vascular remodelling 31 . Our data clearly demonstrated that elevated NOSTRIN levels in the mesometrial uterus were associated with a decline in expression of genes known to be down regulated by NOSTRIN in vitro 23 . This gene network primarily includes angiogenesis promoting genes. Among the genes that were affected in our study, members of the VEGF family were most prominent. VEGF family members are known for their regulation of vasculogenesis and angiogenesis in the developing placenta [32] [33] [34] . FLT-1/VEGFRI, KDR/VEGFRII and PGF were found be down-regulated on induction of IUGR by maternal administration of dexamethasone. Binding of VEGF proteins to their receptors induces receptor homodimerization or heterodimerization, which in turn activates receptor kinase activity leading to receptor autophosphorylation and downstream signaling. PGF is a ligand for FLT1 known to stimulate developmental angiogenesis 35 . Genetic studies in animal models clearly demonstrate the importance of VEGF signaling in vasculogenesis. Embryos lacking VEGF receptors are embryonic lethal and exhibit severe vascular defects [36] [37] [38] . Our data reveals that there is decline in VEGF receptors in the mesometrial uterus on induction of IUGR.
Other than VEGF receptors, emerging evidence suggests that the Angiopoietin/TIE2 signaling system is critical for development and maintenance of placental vasculature during pregnancy. Deletion of TEK/TIE2 is also embryonic lethal due to failure of the vasculature system to expand 39, 40 . Our data demonstrated that NOSTRIN up-regulation was associated with a reduction in TEK levels in the mesometrial compartment reinforcing the importance of Angiopoietin/TIE2 signaling system in the utero-placental interface.
Cell adhesion molecules not only play a crucial role in invasion of trophoblast cells to the uterine wall, but also aids in degradation and remodelling of basement membrane and surrounding extracellular matrix (ECM) during proliferation of endothelial cells at the onset of angiogenesis. NOSTRIN mediated down-regulation of ITGβ3, ITGα5 and FN1 has been recently demonstrated 23 . During IUGR, there was a decrease in these adhesion molecules along with an increase in NOSTRIN levels in the metrial gland. Apart from these adhesion molecules COL18A1 which is a component of the ECM itself was reduced during IUGR. Our data highlight the importance of regulatory role of adhesion markers in metrial gland during IUGR. Proteolytic enzymes are well known to promote neovascularisation by aiding in degradation of the basement membrane and the ECM leading to formation of new vessels. A decline in expression of ADAM17, MMP2 and PLAU were associated with up-regulation of NOSTRIN in the mesometrial compartment during IUGR. Several reports suggest that these proteases also potentiates cancer progression [41] [42] [43] since they aid in angiogenesis. Our data extends the importance of protease in the pathogenesis of IUGR.
Altogether, our study suggests that there was a decline in several NOSTRIN-regulated genes that might contribute to functional restriction in vascular development, particularly affecting the metrial gland on maternal administration of dexamethasone, leading to IUGR. Interestingly, most of the genes that were found to be regulated in the mesometrial triangle of the uterus during IUGR possess NFκB binding element in their promoter. Phosphorylation of Ser-536 of p65/RelA leads to trans-activation by increased binding of CBP (CREB binding protein) and subsequent acetylation of p65 44, 45 . Our data clearly depicts that RelA phosphorylation was suppressed during IUGR. These data are in line with our results on down-regulation of the genes and cytokines that include IL6, CCL2, CXCL1 and CXCL2 in the mesometrial uterus which are direct targets of RelA transcription factor. However, there are earlier reports of Th1 bias and increased levels of inflammatory cytokine in IUGR cases as compared to normal pregnancy [46] [47] [48] [49] . These enhanced levels of proinflammatory cytokines are secreted primarily either by PBMC or by trophoblast cells of the placenta. Our results show decreased levels of proinflammatory cytokines in the metrial gland which is rich in vasculature and is the entry point of placental arteries. Our data, therefore, indicates that down regulation of these cytokines by tissue specific modulators might be a consequence or compensatory response to prevent the placental insufficiency during IUGR.
Vascular manifestations of IUGR are often attributed to clinical conditions that lead to hypoxia [50] [51] [52] [53] . Hypoxia-inducible factor (HIF) is a transcription factor comprising of a constitutively active HIF-1β subunit and an oxygen-sensitive HIF1α subunit. HIF-1α levels are low under normal conditions as it is rapidly degraded whereas hypoxia leads to its accumulation. HIF-1α forms a heterodimer with HIF-1β and binds to promoters of several target genes to activate transcription. In our model of dexamethasone induced IUGR there was a reduction in HIF-1α levels in the metrial gland along with an increase in NOSTRIN. Thus our data suggests that the mesometrial compartment of the uterus is not susceptible to the effect of hypoxia, unlike other placental zones. This reciprocal expression pattern of HIF-1α and NOSTRIN in the mesometrial uterus along with the presence Altogether our data provides evidence that HIF-1a might be regulating NOSTRIN expression in the mesometrial uterus during IUGR. IUGR is primarily a consequence of placental insufficiency that leads to deregulation in cellular homeostasis. Hypoxia induces autophagy in various cell types 54 . Increased autophagy has been demonstrated in placenta during IUGR and in cytotrophoblasts cultured under hypoxic stress 55 . Autophagy might be an adaptive mechanism to promote cell survival under stressed conditions. Induction of hypoxia in endothelial cells in a time dependent manner was indeed associated with a gradual up-regulation in autophagy markers such as Beclin1 and LC3II ( Figure S1 ). Anti-apoptotic Bcl2 levels also increase suggesting a state where cells try to prevent apoptosis by promoting autophagy. mTORC activity was not affected (Data not shown) precluding nutrient starvation. A vast majority of long lived or protein aggregates including organelles are degraded by autophagy 56 under stress conditions to recycle cellular components and promote cell survival. Thus decresed NOSTRIN levels by induction of hypoxia might also be a consequence of increased autophagy in the endothelial cells.
In summary, we demonstrate here a network of genes, known to be affected by NOSTRIN over expression in vitro, is down-regulated along with up regulation of NOSTRIN in the mesometrial uterus on induction of IUGR by dexamethasone treatment. Furthermore, there is remarkable curtailment of pro-inflammatory secreted cytokines such as IL6, CCL2, CXCL1 and CXCL2 in mesometrial triangle of the uterus during IUGR. In addition, RelA phosphorylation is suppressed during IUGR. Furthermore, HIF-1α, the master transcriptional regulator of hypoxia appears to negatively regulate NOSTRIN both in vitro and in vivo. A schematic representation of our findings is depicted in Fig. 8 .
Methods
Animals and tissue preparation. Sprague Dawley rats (8-10 weeks old) were obtained Indian Institute of Chemical Biology (IICB) animal house. To obtain timed pregnancies, female rats were caged overnight with fertile males. Day 0.5 of pregnancy was denoted by the presence of sperm in morning vaginal smears. On Day 13.5 of pregnancy, 5 pregnant rats were subcutaneously injected with a bolus dose of 100 μg of Dexamethasone acetate (Sigma Aldrich, St. Louis, MO, USA) dissolved in 100 µl 10% ethanol. Control group of 5 pregnant rats were injected with vehicle only. Alzet osmotic pumps (Model 2 ML1, Durect Corp., Cupertino, CA, USA) were surgically implanted subcutaneously in the two groups of control and treated rats. The alzet pumps were pre-calibrated to release 200 μg of dexamethasone per kg of maternal body weight per day. Control group received osmotic pumps containing vehicle only. This model of IUGR in rats by dexamethasone treatment was previously established 7 . Animals were sacrificed on Day 20.5 of pregnancy. Placental and fetal weight was recorded for each of the rats. Utero-placental tissues were collected from control and dexamethasone treated rats and either snap-frozen in liquid nitrogen for RNA and protein analysis or frozen in dry-ice chilled heptane for haematoxylin and eosin staining. All tissue samples were stored at −80 °C until use. Enzyme-linked Immunosorbent Assay (ELISA). Metrial gland tissues from control and IUGR rats were homogenised in tissue extraction buffer containing 1 mM Na 2 EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 0.2 mM PMSF, and 1 mM sodium orthovanadate dissolved in DPBS (pH 7.4) and supplemented with protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO, USA). Samples were centrifuged and supernatant was collected and stored at −80 °C until use. Expression of IL6, CCL2, CXCL1 and CXCL2 were determined using Rat IL6 Quantikine ELISA Kit (R6000B), Rat MCP1 Quantikine ELISA kit (MJE00), Rat CXCL1/CINC1 Quantikine ELISA Kit (RCN100) and Rat CXCL2/CINC3 Quantikine ELISA Kit (RCN300) respectively as per manufacturer's instruction (R&D Systems, Minneapolis, MN USA). 
Antibodies. Anti

Statistical analysis.
All experiments were performed using 5 different biological replicates and data were expressed as mean ± standard error of the mean (SEM). Statistical significance was assessed by the Student's t-test. Two-sided p < 0.05 was considered significant for the mean values.
